Oculomucocutaneous syndrome
From Wikipedia, the free encyclopedia
| Oculomucocutaneous syndrome | |
|---|---|
| Specialty | Ophthalmology |
Oculomucocutaneous syndrome is characterized by keratoconjunctivitis sicca (dry eyes) and the resulting scarring, fibrosis, metaplasia, and shrinkage of the conjunctiva.[1] It is a drug side effect observed in practolol and eperisone. It is speculated that antibodies against drug metabolites cause the syndrome.[2]
